Francine Breuzard

Title: Francine Breuzard: Innovator in Pharmaceutical Compounds

Introduction

Francine Breuzard is a notable inventor based in Quincy Sous Senart, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various medical conditions. With a total of 2 patents, her work has the potential to impact numerous therapeutic areas.

Latest Patents

Her latest patents include innovative triazolo compounds that act as MMP inhibitors. These compounds, specifically 1-amino triazolo[4,3-a]quinazoline-5-ones and/or -5-thiones, have been shown to inhibit phosphodiesterase IV (PDE-4). The invention encompasses racemic forms, isomers, and pharmaceutically acceptable salts, along with methods for their production. The compounds are designed to treat a variety of conditions, including asthma, chronic bronchitis, and even certain types of cancer.

Career Highlights

Throughout her career, Francine has worked with prominent companies such as Warner-Lambert Company and Warner Lambert LLC. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical research and development.

Collaborations

Francine has collaborated with notable colleagues, including Charles Andrianjara and Bernard Gaudilliere. These partnerships have contributed to her innovative work and the advancement of her research.

Conclusion

Francine Breuzard is a pioneering inventor whose contributions to pharmaceutical compounds are noteworthy. Her patents and collaborations reflect her commitment to advancing medical science and improving patient care.